Skye Bioscience, Inc. (NASDAQ:SKYE) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Joel, and I will be your conference operator today.
Skye Bioscience Inc. (SKYE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,450,638 | $6,063,667 | 0.06% | |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 1,097,864 | $4,589,069 | -33% | 0.03% |
| 3. | Driehaus Capital Richard Driehaus | 620,395 | $2,593,251 | 0.02% | |
| 4. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 538,434 | $2,250,654 | -64% | 0.53% |
| 5. | Millennium Management Israel Englander | 470,729 | $1,967,647 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.00 | 450,000 | $4,500,000.00 | 8,393,520 | 2024-03-13 | Filing | |
| $2.31 | 5,206,074 | $12,026,030.94 | 7,943,520 | 2024-01-31 | Filing | |
| $0.02 | 881,000 | $16,474.70 | 25,683,957 | 2023-08-29 | Filing | |
| $0.02 | 881,000 | $16,474.70 | 41,554,828 | 2023-08-29 | Filing | |
| $100,000.00 | 1,000,000 | $100,000,000,000.00 | 1,000,000 | 2020-08-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.42 | 6,470 | $22,127.40 | 57,493 | 2025-08-22 | Filing | |
| $3.42 | 163,979 | $560,808.18 | 1,457,064 | 2025-08-22 | Filing | |
| $3.57 | 2,314 | $8,260.98 | 63,963 | 2025-08-21 | Filing | |
| $3.57 | 58,642 | $209,351.94 | 1,621,043 | 2025-08-21 | Filing | |
| $3.42 | 6,470 | $22,127.40 | 57,493 | 2025-08-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 44,517 | $174,952 | 0.02% | |
| 2. | 114 | $448 | 0% | |
| 3. | 1 | $4 | 0% | |
| 4. | 90 | $0 | 0% |
News See All
Skye Bioscience Highlights Nimacimab's Promise in Obesity Treatment, Anticipates Phase 2a Data
Skye Bioscience Inc. (NASDAQ:SKYE) is one of the best hot stocks to buy according to Wall Street analysts.
11 Best Hot Stocks to Buy According to Wall Street Analysts
On July 1, Ralph Schlosstein, Evercore's chairman emeritus and BlackRock's co-founder, joined 'Closing Bell Overtime' on CNBC to talk about his outlook for markets heading into the second half of the ...
7 Best Russell 2000 Stocks to Buy According to Analysts
The investor sentiment remains bullish toward the market, especially since the Fed's recent decision to cut interest rates by half a percentage point, which is seen as a move to sustain economic health...
Hedge Fund Resource Center Billionaire Hedge Funds
